Xiaowen R. Gong

No. 5 JingYuan Road
Shijingshan, 100043, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Receptiveness of physicians towards artificial intelligence-driven drug prescription: a nationwide survey.

Receptiveness of physicians towards artificial intelligence-driven drug prescription: a nationwide survey.

Journal: npj health systems

Published: January 06, 2026

Correction: Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.

Correction: Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.

Journal: JMIR research protocols

Published: September 04, 2025

Alternative-Donor Transplants in Adults ≤ 55 Years Old With Haematological Cancers: Young Versus Older Related HLA-Haplotype-Mismatched Donor Versus Unrelated Umbilical Cord Blood.

Alternative-Donor Transplants in Adults ≤ 55 Years Old With Haematological Cancers: Young Versus Older Related HLA-Haplotype-Mismatched Donor Versus Unrelated Umbilical Cord Blood.

Journal: Clinical transplantation

Published: June 04, 2025

Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.

Factors Affecting the Receptiveness of Chinese Internists and Surgeons Toward Artificial Intelligence-Driven Drug Prescription: Protocol for a Systematic Survey Study.

Journal: JMIR research protocols

Published: April 21, 2025

Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants.

Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants.

Journal: Nature communications

Published: March 18, 2025

Challenges determining the best target duration of deep molecular response after which to attempt achieving therapy-free remission in chronic myeloid leukaemia.

Challenges determining the best target duration of deep molecular response after which to attempt achieving therapy-free remission in chronic myeloid leukaemia.

Journal: Leukemia

Published: December 30, 2024

New criteria for estimating numbers of CD34-positive cells in a graft needed for posttransplant bone marrow recovery.

New criteria for estimating numbers of CD34-positive cells in a graft needed for posttransplant bone marrow recovery.

Journal: Leukemia

Published: September 12, 2024

Corrigendum to "Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?"[BLOOD REVIEWS, 9 August 2024, https://doi.org/10.1016/j.blre.2024.101226].

Corrigendum to "Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?"[BLOOD REVIEWS, 9 August 2024, https://doi.org/10.1016/j.blre.2024.101226].

Journal: Blood reviews

Published: September 07, 2024

Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?

Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?

Journal: Blood reviews

Published: June 20, 2024

Gene expression prognostic of early relapse risk in low-risk B-cell acute lymphoblastic leukaemia in children.

Gene expression prognostic of early relapse risk in low-risk B-cell acute lymphoblastic leukaemia in children.

Journal: EJHaem

Published: January 30, 2024

Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?

Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?

Journal: Leukemia

Published: August 30, 2023

Have we been qualifying measurable residual disease correctly?

Have we been qualifying measurable residual disease correctly?

Journal: Leukemia

Published: July 21, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026